(1) Liu E, Shi S, Li J, Ge R, Liang T, Li Q*; Farrerol maintains the contractile phenotype of VSMCs via inactivating the extracellular signal-regulated protein kinase 1/2 and p38 mitogen-activated protein kinase signaling.Mol Cell Biochem. 2020, 475(1-2):249-260. (2) Liu E#; Li J#; Shi S#; Wang X; Liang T; Wu B; Li Q*; Sustained ERK activation mediated proliferation inhibition of farrerol on human gastric carcinoma cell line via G0/G1-phase cell-cycle arrest, European Journal of Cancer Prevention, 2016, 25(6): 490-499. (3) Liu E#; Liang T#; Wang X; Ban S; Han L; Li Q*; Apoptosis Induced by Farrerol in Human Gastric Cancer SGC-7901 Cells via Mitochondrial-mediated Pathway, European Journal of Cancer Prevention, 2015, 24 (5): 365–372. (4) Liu E#; Du X#; Ge R; Liang T; Niu Q; Li Q*; Comparative toxicity and apoptosis induced by diorganotins in rat pheochromocytoma (PC12) cells, Food and Chemical Toxicology, 2013，60(2013): 302–308. (5) Chaoqun Yan; Xiaoyan Zhang; Junqiu Miao; Hongxia Yuan; Enli Liu; Taigang Liang*; Qingshan Li*; Farrerol Directly Targets GSK-3βto Activate Nrf2-ARE Pathway and Protect EA.hy926 Cells against Oxidative Stress-Induced Injuries, Oxidative Medicine and Cellular Longevity; 2020, 2020: 1-17. (6) HongXia Yuan#; XiuE Feng#; EnLi Liu; Rui Ge; YuanLin Zhang; BaoGuo Xiao; QingShan Li*; 5, 2′-dibromo-2, 4′, 5′-trihydroxydiphenylmethanone attenuates LPS‐induced inflammation and ROS production in EA.hy926 cells via HMBOX1 induction, Journal of Cellular and Molecular Medicine, 2019, 23(1): 453-463. |